Browse Tenders

Showing 308,594 tenders

289381
Administration & Marketing Dec 7 Locked

Spaceport Infrastructure Maintenance And Operations (Simo)

Daniel Hinsley

Spaceport Infrastructure Maintenance And Operations (Simo)<p><u>11/09/2026 - Update</u></p><p>The purpose of this notice is to provide Government responses to i...

United States
Deadline: Dec 7, 2026
6 views
Unlock & View →
289382
Jun 29 Locked

Solicitation: W912Ch-26-B-0006 Nozzle, Fuel, Oil; Nsn: 4930-01-440-1085 - Amended

Robin Walker,Ciara Woodard-Brown

Solicitation: W912Ch-26-B-0006 Nozzle, Fuel, Oil; Nsn: 4930-01-440-1085 - Amended <p><strong>Please note new POC is Lyndsey Pena (lyndsey.m.pena.civ@army.mil)....

United States
Deadline: Jun 29, 2029
10 views
Unlock & View →
289383
Jun 5 Locked

Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient hydroxycarbamide (excl. Dafo. FTA), ATC L01XX05 f. d. Z. August 1st, 2026 - July 31st, 2028 (plus V. option 1x12 months)

DAK HEALTH

<br/>§ 130a Paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the medicines to be ...

€1.00
Germany
Deadline: Jun 5, 2029
12 views
Unlock & View →
289384
Jun 12 Locked

Referencing suppliers for fuel supply

PUBLIC TRANSPORT PURCHASING CENTER

<br/>The purpose of this Qualification System (SdQ) is to select one or more economic operators with a view to awarding specific contracts relating to the suppl...

France
Deadline: Jun 12, 2041
26 views
Unlock & View →
289385
Aug 28 Locked

Orders for vehicle insurance services through the CPO LT electronic catalog

PUBLIC INSTITUTION CPO LT

<br/>The validity period of the Dynamic Purchase System is extended<br/>

Lithuania
Deadline: Aug 28, 2027
10 views
Unlock & View →
289386
May 31 Locked

Open house drug discount agreements for the active ingredient desloratadine, ATC R06AX27

AOK RHINELAND-PALATINATE/SAARLAND - THE HEALTH INSURANCE FUND

<br/>Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit o.g. Wirkstoff innerhalb des Zeitraumes vom 01.08.20...

Germany
Deadline: May 31, 2028
7 views
Unlock & View →
289387
Jun 5 Locked

Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Palonosetron (excl. Dafo. WKA), ATC A04AA05 f. d. Z. August 1, 2026 - July 31, 2028 (plus V. option 1x12 months)

DAK HEALTH

<br/>§ 130a Paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the medicines to be ...

€1.00
Germany
Deadline: Jun 5, 2029
9 views
Unlock & View →
289388
May 31 Locked

Open house drug discount agreements for the active ingredient hydrocortisone, ATC H02AB09

AOK RHINELAND-PALATINATE/SAARLAND - THE HEALTH INSURANCE FUND

<br/>Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit o.g. Wirkstoff innerhalb des Zeitraumes vom 01.08.20...

Germany
Deadline: May 31, 2028
5 views
Unlock & View →
289389
May 31 Locked

Open house drug discount agreements for the active ingredient ustekinumab, ATC L04AC05

AOK RHINELAND-PALATINATE/SAARLAND - THE HEALTH INSURANCE FUND

<br/>Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit o.g. Wirkstoff innerhalb des Zeitraumes vom 01.08.20...

Germany
Deadline: May 31, 2028
11 views
Unlock & View →
289390
Jun 5 Locked

Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Ofloxacin (excl. Dafo. KPG), ATC S01AE01 f. d. Z. August 1, 2026 - July 31, 2028 (plus V. option 1x12 months)

DAK HEALTH

<br/>§ 130a Paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the medicines to be ...

€1.00
Germany
Deadline: Jun 5, 2029
11 views
Unlock & View →
289391
Jun 5 Locked

Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient nifedipine, ATC C08CA05 for the period August 1st, 2026 - July 31st, 2028 (plus extension option 1x12 months)

DAK HEALTH

<br/>§ 130a Paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the medicines to be ...

€1.00
Germany
Deadline: Jun 5, 2029
9 views
Unlock & View →
289392
Jun 5 Locked

Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient granisetron (excl. Dafo. PFT), ATC A04AA02 f. d. Z. August 1, 2026 - July 31, 2028 (plus V. option 1x12 months)

DAK HEALTH

<br/>§ 130a Paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the medicines to be ...

€1.00
Germany
Deadline: Jun 5, 2029
9 views
Unlock & View →
289393
Jun 5 Locked

Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient varenicline, ATC N07BA03 for the period August 1st, 2026 - July 31st, 2028 (plus extension option 1x12 months)

DAK HEALTH

<br/>§ 130a Paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the medicines to be ...

€1.00
Germany
Deadline: Jun 5, 2029
8 views
Unlock & View →
289394
May 31 Locked

Open house drug discount agreements for the active ingredient alitretinoin, ATC D11AH04

AOK RHINELAND-PALATINATE/SAARLAND - THE HEALTH INSURANCE FUND

<br/>Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit o.g. Wirkstoff innerhalb des Zeitraumes vom 01.08.20...

Germany
Deadline: May 31, 2028
9 views
Unlock & View →
289395
Jun 3 Locked

Open house drug discount agreements Ustekinumab, ATC L04AC05

AOK BAYERN - THE HEALTH INSURANCE COMPANY

<br/>It is not an open procedure, but rather a so-called open-house model! The form for the open process is only used because there is no form for the open-hous...

Germany
Deadline: Jun 3, 2028
9 views
Unlock & View →
289396
Jun 5 Locked

Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient budesonide (FAM Kinpeygo and interchangeable medicines), ATC A07EA06 for the period August 1st, 2026 - July 31st, 2028

DAK HEALTH

<br/>§ 130a Paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the medicines to be ...

€1.00
Germany
Deadline: Jun 5, 2028
7 views
Unlock & View →
289397
May 31 Locked

Open house drug discount agreements for the active ingredient lisdexamfetamine, without hard capsules in a pack size of 30, ATC N06BA12

AOK RHINELAND-PALATINATE/SAARLAND - THE HEALTH INSURANCE FUND

<br/>Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit o.g. Wirkstoff innerhalb des Zeitraumes vom 01.08.20...

Germany
Deadline: May 31, 2028
7 views
Unlock & View →
289398
Oct 3 Locked

GCS UniHA - Maintenance in Medical Imaging (MAINTIM 2020) SAD

GCS UNIHA

<br/>Maintenance in Medical Imaging (MAINTIM 2020) SAD<br/><br/>LOT-0001<br/>Cf. DCE<br/>

€429,600,000.00
France
Deadline: Oct 3, 2027
18 views
Unlock & View →
289399
Jul 17 Locked

dynamic acquisition system relating to the purchase and leasing of vehicles

MINISTRY OF THE FRENCH COMMUNITY

<br/>dynamic acquisition system relating to the purchase and leasing of vehicles intended for the Administration and ministerial cabinets of the French Communit...

Belgium
Deadline: Jul 17, 2030
15 views
Unlock & View →
289400
May 31 Locked

Open house drug discount agreements for the active ingredient naloxegol, ATC A06AH03

AOK RHINELAND-PALATINATE/SAARLAND - THE HEALTH INSURANCE FUND

<br/>Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit o.g. Wirkstoff innerhalb des Zeitraumes vom 01.08.20...

Germany
Deadline: May 31, 2028
15 views
Unlock & View →